Allox

About

Allox (legal name Allostery Exploration Technologies, S.L.) is a biotechnology company developing an experimental and AI-enabled platform for the systematic discovery of allosteric drug targets. It is a spin-out of the Centre for Genomic Regulation (CRG). The company release is datelined Barcelona and its about line calls Allox Barcelona-based. FinSMEs and the Raise Track Update say Barcelona, Spain. This page stores Barcelona, Spain. The company site is https://www.allox.bio.

The GlobeNewswire release is timestamped October 29, 2026, 04:30 ET (08:30 UTC), so the round date is 2026-10-29. The release states a US$10.5m (€9.4m) seed round. Tech.eu, FinSMEs, and the issue say $10.5 million. The company states the US dollar figure as the round amount, so $10,500,000 is stored, as with earlier rounds announced in two currencies. The euro figure is not stored.

Asabys led, through its Sabadell Asabys II fund. CDTI, through its SICC Innvierte, and the Institut Català de Finances (ICF) participated. Morten Graugaard was named Independent Chair of the Board and does not have a page. A media contact on the release is not published.

Funding history

Investors

• Asabys lead
• CDTI participant
• Institut Català de Finances (ICF) participant

Sources

Last verified: 2026-10-29

1. https://www.globenewswire.com/news-release/2026/10/29/3390985/0/en/allox-closes-10-5m-seed-financing-and-appoints-morten-graugaard-as-chair-to-scale-allosteric-drug-discovery-platform-and-build-pipeline.html
   Type: funding announcement. Accessed 2026-10-29.
   GlobeNewswire release, source ALLOX, October 29, 2026, 04:30 ET (08:30 UTC). Dateline BARCELONA, Spain. Announces the closing of a US$10.5m (€9.4m) seed round led by Asabys, through its Sabadell Asabys II fund, with participation from CDTI with its SICC Innvierte and the Institut Català de Finances (ICF). The about line says ALLOX (Allostery Exploration Technologies, S.L.) is a Barcelona-based biotechnology company and a spin-out of the Centre for Genomic Regulation (CRG), and gives www.allox.bio. Morten Graugaard is named Independent Chair and does not have a page. A media contact email and phone number are not published. This is the earliest timestamp read here, so the round date is 2026-10-29.
2. https://tech.eu/2026/10/29/allox-closes-105m-seed-financing-to-scale-drug-discovery-platform/
   Type: reputable publication. Accessed 2026-10-29.
   Tech.eu, Tamara Djurickovic, October 29, 2026. Says ALLOX raised $10.5 million in a seed round led by Asabys through its Sabadell Asabys II fund, with participation from CDTI through SICC Innvierte and the Institut Català de Finances (ICF).
3. https://www.finsmes.com/2026/10/allox-raises-10-5m-in-seed-funding.html
   Type: reputable publication. Accessed 2026-10-29.
   FinSMEs, October 29, 2026. Says Allox, a Barcelona, Spain-based provider of an allosteric drug discovery platform, raised $10.5M (€9.4M) in seed funding, led by Asabys with participation from CDTI (via its SICC Innvierte) and Institut Català de Finances (ICF).
4. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-29/
   Type: other verified public source. Accessed 2026-10-29.
   Raise Track Update for 2026-10-29, Section 1. Amount line $10.5M (Seed). Says a Barcelona, Spain-based provider of an allosteric drug discovery platform raised $10.5M (€9.4M) in seed funding, led by Asabys with participation from CDTI (via its SICC Innvierte) and Institut Català de Finances (ICF).